EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-drug resistant ovarian carcinoma cells develop increased complement resistance



Multi-drug resistant ovarian carcinoma cells develop increased complement resistance



Molecular Immunology 38(2-3): 114, August




(PDF 0-2 workdays service: $29.90)

Accession: 035349147

Download citation: RISBibTeXText



Related references

Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells. Clinical and Experimental Immunology 155(2): 239-248, 2008

Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro. Zhonghua Fu Chan Ke Za Zhi 44(9): 686-690, 2011

Differential sensitivity of multi drug resistant and multi drug sensitive cells to resistance modifying agents and the relation with reversal of anthracycline resistance. International Journal of Cancer 46(2): 330-336, 1990

The combined effects of alpha interferon with doxorubicin and vinblastine on multi drug resistant ovarian carcinoma and leukemic cells. Proceedings of the American Association for Cancer Research Annual Meeting 30: 528, 1989

The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma. Zhonghua Fu Chan Ke Za Zhi 32(8): 462-466, 1997

Reversal effect of Fe3O4-magnetic nanoparticles on multi-drug resistance of ovarian carcinoma cells and its correlation with apoptosis-associated genes. Ai Zheng 28(11): 1158-1162, 2011

Mitochondrial dna depletion of cisplatin resistant human ovarian carcinoma cells is accompanied by loss of drug resistance. Proceedings of the American Association for Cancer Research Annual Meeting 33: 537, 1992

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids and Surfaces. B, Biointerfaces 110: 74-80, 2014

Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning. Cancer Cell International 11(): 3-3, 2011

Multi-drug resistant leukemic cells highly express HLA class I molecules and single-chain Fv diabody specific to HLA-A overcomes drug resistance in these cells. 2007

The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562/ADM cells. Zhonghua Yi Xue Za Zhi 89(25): 1741-1744, 2010

Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma. Toxicology in Vitro 28(8): 1498-1506, 2015

Absence of cross resistance to morpholinocarminomycin in multi drug resistant cells correlation with drug accumulation and dna damage. Proceedings of the American Association for Cancer Research Annual Meeting 31: 367, 1990

Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene. Archives of Gynecology and Obstetrics 279(2): 149-157, 2008

Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance. Oncotarget (): -, 2016